Page 7 - JCTR-11-1

Journal of Clinical and

Translational Research

EDITORIAL
Clinical and translational medicine in the heart

of JCTR

Jacek Z. Kubiak *
1,2
1 Institute of Genetics and Development of Rennes, UMR 6290, CNRS, Faculty of Medicine,
University of Rennes, Rennes, France
2 Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine – National
Research Institute, Szaserow, 128, Warszawa, Poland

1. Introduction
The two main areas of medicine, namely clinical and translational medicine, are the
primary focus of the Journal of Clinical and Translational Research (JCTR) – a journal that
we wish would become the leading platform for dissemination and scientific exchange of
medical discoveries and applications. The current issue features a collection of excellent
articles covering the two above-mentioned areas, representative of the journal’s scope.
This editorial will present an overview of the papers included in the current issue,
highlighting the significance of the authors’ works.
2. Scope and spectrum of our journalistic activity

Rapidly developing biomedical research requires rapid worldwide dissemination, which
aligns with JCTR’s main goal of delivering our content to the audience at the fastest
speed possible. The content of our journal is very diverse since both key areas, namely
*Corresponding author: clinical medicine and translational medicine, are covered by the journal. Moreover, we
Jacek Z. Kubiak
(jacek.kubiak@univ-rennes.fr) cover the whole spectrum of biomedical research from in silico and in vitro to in vivo and
ex vivo studies conducted on both animal models and human patients. Epidemiologic
Citation: Kubiak JZ. Clinical studies also constitute a significant part of our articles, encompassing works at both the
and translational medicine in the
heart of JCTR. J Clin Transl Res. regional and global levels. We believe having a diverse scope, covering works from a
2025;11(1):1-3. variety of medical and clinical specialties, is our strength to meeting multiple challenges
doi: 10.36922/JCTR025090012 encountered at clinical settings.
Received: February 26, 2025
3. What can we find in the current issue of JCTR?
Published online: March 4, 2025
The original article “Dexamethasone in critical coronavirus disease-2019 cases: Insights
Copyright: © 2025 Author(s).
This is an open-access article from a cross-sectional study” by Francine Johansson Azeredo and colleagues focuses on
distributed under the terms of the the survey of COVID-19 patients with comorbidities in Bahia, Brazil. Their findings
Creative Commons AttributionNon- contribute to the full description of the clinical course of SARS-CoV-2 infection. 1
Commercial 4.0 International (CC
BY-NC 4.0), which permits all A commentary “Reprogramming of lipid droplets by host cells as a defense mechanism
non-commercial use, distribution,
and reproduction in any medium, against viral infection” by Chunfu Zheng from the University of Calgary, Canada,
provided the original work is deals with the not-yet-well-explored virus-host interactions consisting of host cells
properly cited. reprograming of lipid droplets as a response to viral infection. The model system referred
Publisher’s Note: AccScience to in this paper is the porcine reproductive and respiratory syndrome virus (PRRSV) that
Publishing remains neutral with attacks the porcine alveolar macrophages (PAMs). This paper focuses on the role of the
regard to jurisdictional claims in
published maps and institutional transcription factor YY1 in reprogramming lipid droplet content to promote resistance
affiliations to viral infection. 2

Volume 11 Issue 1 (2025) 1 doi: 10.36922/JCTR025090012